ABSTRACT
OBJECTIVE: To evaluate the clinical effects of thymectomy in treatment of myasthenia gravis: (MG). METHODS: The clinical data of 67 patients, 29 males and 38 females, aged 10.5 - 68, who underwent thymectomy were analyzed. RESULTS: According to the Monden's standard the overall effective rate of thymectomy was 71.6%. The remission rate was 32.8% (22/6), the improvement rate was 38.8% (26/67), 14 patients showed no change (20.9%), and deterioration was seen in 5 patients (7.5%). CONCLUSION: An effective method to treat MG, thymectomy should be performed on most of the MG patients early and actively.
Subject(s)
Myasthenia Gravis/surgery , Thymectomy , Adolescent , Adult , Aged , Child , Female , Follow-Up Studies , Humans , Male , Middle Aged , Myasthenia Gravis/pathology , Retrospective StudiesABSTRACT
OBJECTIVE: To study the therapeutic result of operation combined chemotherapy for stage IIIa non-small cell lung cancer. METHODS: From January 2000 to December 2003, the data of 83 cases with stage IIIa non-small cell lung cancer undergoing operation combined chemotherapy and 33 cases with stage IIIa non-small cell lung cancer undergoing non-operative therapy were retrospectively analyzed. The median survival time and the 1-, 2-, 3- year survival rates of the two groups were compared by the Kaplan-Meier method. RESULTS: The median survival time of the operation group was 20.3 months, and the 1-, 2-, 3- year survival rates were 85%, 70%, and 35% respectively. The median survival time of the non-operation group was 14.5 months and the 1-, 2-, 3- year survival rates were 75%, 33%, and 15% respectively. CONCLUSION: The therapeutic result of the operation combined chemotherapy for the stage IIIa non-small cell lung cancer is better than that of the non-operative therapy obviously.
